这10例患者的中位生存时间为19个月。
其中19例单纯卵巢转移患者的中位生存时间31个月，43例卵巢合并其他部位转移患者的中位生存时间21个月。
The median survival time of 19 patients with simple ovary metastasis was 31 months, while that of 43 patients with ovary and other organ metastasis was 21 months.
结果：本组盆腔淋巴结阴性患者的五年总体生存率为82 0 %，中位生存时间10 0 0月。
Results: the overall 5-year survival of the patients was 82.0% and the median survival time was 100.0 months.
所有患者中位随访时间35.8个月，80例出现复发或转移，40例死亡，中位生存期未达到，中位无疾病生存期（DFS）为24.1个月。
After a median follow-up of 35.8 months, 80 patients experienced metastatic or recurrent tumors and 40 patients died. The median overall survival was not reached and the median DFS was 24.1 months.
所有患者中位随访时间35.8个月，80例出现复发或转移，40例死亡，中位生存期未达到，中位无疾病生存期（DFS）为24.1个月。
After a median follow-up of 35.8 months, 80 patients experienced metastatic or recurrent tumors and 40 patients died. The median overall survival was not reached and the median DFS was 24.1 months.
应用推荐